{"id":19976,"date":"2026-06-11T23:14:00","date_gmt":"2026-06-11T21:14:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=a54f736f041443b4a50e6b0521dc707b"},"modified":"2026-06-11T23:14:00","modified_gmt":"2026-06-11T21:14:00","slug":"securities-fraud-investigation-into-erasca-inc-eras-announced-shareholders-who-lost-money-urged-to-contact-the-law-offices-of-frank-r-cruz","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=19976","title":{"rendered":"Securities Fraud Investigation Into Erasca, Inc. (ERAS) Announced \u2013 Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz<\/a> announces an investigation of Erasca, Inc. (\u201cErasca\u201d or the \u201cCompany\u201d) (NASDAQ: ERAS<\/a>) on behalf of investors concerning the Company\u2019s possible violations of federal securities laws.<\/p><\/a><\/a>

\nIF YOU ARE AN INVESTOR WHO LOST MONEY ON ERASCA, INC. (ERAS), CLICK <\/b>HERE<\/b><\/a> TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.<\/b><\/p>

\nWhat Is The Investigation About?<\/b><\/p>

\nOn April 27, 2026, before market hours, Erasca disclosed that it had received a letter from legal counsel for Revolution Medicines, Inc. (\u201cRevMed\u201d) alleging that Erasca\u2019s drug candidate, ERAS-0015, infringes a RevMed patent and is connected to alleged trade secret misappropriation. RevMed also claimed that Erasca had \u201cimproperly compared preclinical data of ERAS-0015 and RMC-6236 in public disclosures\u201d and demanded Erasca cease making \u201cdeceptive and untrue comparative statements comparing ERAS-0015 and RMC-6236.\u201d<\/p>

\nOn this news, Erasca\u2019s stock price fell $2.34, or 10.9%, to close at $19.15 per share on April 27, 2026, thereby injuring investors.<\/p>

\nThat same day, after market hours, Erasca reported preliminary Phase 1 clinical data from ERAS-0015, revealing that a patient had died approximately one month after starting ERAS-0015.<\/p>

\nOn this news, Erasca\u2019s stock price fell $9.25, or 48.3%, to close at $9.90 per share on April 28, 2026, thereby injuring investors further.<\/p>

\nContact Us To Participate or Learn More:<\/b><\/p>

\nIf you purchased Erasca securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:<\/p>

\nThe Law Offices of Frank R. Cruz,\n2121 Avenue of the Stars, Suite 800,\nCentury City, California 90067\nCall us at: 310-914-5007\nEmail us at: info@frankcruzlaw.com<\/a>Visit our website at: www.frankcruzlaw.com<\/a>.\nFollow us for updates on Twitter at twitter.com\/FRC_LAW<\/a>.<\/p>

\nIf you inquire by email, please include your mailing address, telephone number, and number of shares purchased.<\/p>

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

\nContact Us:\n<\/b>The Law Offices of Frank R. Cruz, Los Angeles\nFrank R. Cruz\n310-914-5007\nfcruz@frankcruzlaw.com<\/a>www.frankcruzlaw.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces an investigation of Erasca, Inc. (\u201cErasca\u201d or the \u201cCompany\u201d) (NASDAQ: ERAS) on behalf of investors concerning the Company\u2019s possible violations of federal securities laws.
\nIF YOU …<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-19976","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/19976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19976"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/19976\/revisions"}],"predecessor-version":[{"id":19977,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/19976\/revisions\/19977"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}